Ebola: MSF launches its first test of three possible treatments in Africa

The goal is to try to find an effective therapy against the epidemic in several countries in western Europe such as Guinea, Liberia and Sierra Leone.

In the absence of specific treatment, "the disease currently kills between 50 and 80% of those infected," according to Doctors Without Borders, one of the main operators of care locally engaged.

The World Health Organization is associated with these tests that will be placed under the authority of the University of Oxford with the antiviral drug brincidofovir Liberia. INSERM, the French Institute for Health and Medical Research will use his hand to the antiviral drug Favipiravir Guéckédou Guinea. And the Institute of Tropical Medicine Antwerp use a therapy based on blood and plasma from convalescent in Conakry, the Guinean capital.

According to the latest toll released yesterday by the WHO, the Ebola outbreak has already killed more than 5,100 deaths over 14 000 cases.

With AFP and Reuters.